Form 8-K SELLAS Life Sciences For: Mar 05

Go back to Form 8-K SELLAS Life Sciences For: Mar 05

SELLAS Life Sciences (SLS) Receives Nasdaq Non-compliance Notice

March 5, 2024 4:12 PM EST

On March 5, 2024, SELLAS Life Sciences (NASDAQ: SLS) received a letter from The Nasdaq Stock Market (Nasdaq) stating that the Company has regained compliance under Nasdaq Listing Rule 5550(b)(2) (the MVLS Rule) by maintaining a market value of the Companys common stock (MVLS) of greater than $35.0 million,... More